These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 30340518)

  • 21. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease.
    Fitz NF; Nam KN; Wolfe CM; Letronne F; Playso BE; Iordanova BE; Kozai TDY; Biedrzycki RJ; Kagan VE; Tyurina YY; Han X; Lefterov I; Koldamova R
    Nat Commun; 2021 Jun; 12(1):3416. PubMed ID: 34099706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
    Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
    Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
    Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
    Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
    Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
    J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.
    Hartlage-Rübsamen M; Waniek A; Meissner J; Morawski M; Schilling S; Jäger C; Kleinschmidt M; Cynis H; Kehlen A; Arendt T; Demuth HU; Rossner S
    Acta Neuropathol; 2015 Apr; 129(4):565-83. PubMed ID: 25666182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.
    Ager RR; Fonseca MI; Chu SH; Sanderson SD; Taylor SM; Woodruff TM; Tenner AJ
    J Neurochem; 2010 Apr; 113(2):389-401. PubMed ID: 20132482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PL201, a Reported Rhamnoside Against Alzheimer's Disease Pathology, Alleviates Neuroinflammation and Stimulates Nrf2 Signaling.
    An Y; Zhang H; Huang S; Pei G
    Front Immunol; 2020; 11():162. PubMed ID: 32174909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
    Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
    Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury.
    Nadler Y; Alexandrovich A; Grigoriadis N; Hartmann T; Rao KS; Shohami E; Stein R
    Glia; 2008 Apr; 56(5):552-67. PubMed ID: 18240300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
    Raha AA; Henderson JW; Stott SR; Vuono R; Foscarin S; Friedland RP; Zaman SH; Raha-Chowdhury R
    J Alzheimers Dis; 2017; 55(1):199-217. PubMed ID: 27662313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
    Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
    J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice.
    Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L
    J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
    Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology.
    Ryu JK; Cho T; Choi HB; Wang YT; McLarnon JG
    J Neurosci; 2009 Jan; 29(1):3-13. PubMed ID: 19129379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway.
    Fang Y; Wang J; Yao L; Li C; Wang J; Liu Y; Tao X; Sun H; Liao H
    J Neuroinflammation; 2018 Jul; 15(1):210. PubMed ID: 30029608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques.
    Sala Frigerio C; Wolfs L; Fattorelli N; Thrupp N; Voytyuk I; Schmidt I; Mancuso R; Chen WT; Woodbury ME; Srivastava G; Möller T; Hudry E; Das S; Saido T; Karran E; Hyman B; Perry VH; Fiers M; De Strooper B
    Cell Rep; 2019 Apr; 27(4):1293-1306.e6. PubMed ID: 31018141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.